Stay updated on Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.

Latest updates to the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a new build deployment for the platform; this does not reflect changes to the page content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, indicating a minor update to the page's version metadata.SummaryDifference0.0%

- Check37 days agoChange DetectedA new revision tag v3.6.4 was added, replacing the previous v3.6.3 tag as part of a routine software version update.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision tag updated to v3.6.3, replacing the previous v3.6.2 on the page. This signals a minor documentation/software update to the page rather than a change in the study data or eligibility details.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing v3.6.0, reflecting a minor update to the page's underlying software.SummaryDifference0.0%

- Check80 days agoChange DetectedEnrollment status shows recruitment is closed. The page now includes new help sections and a formatting update to the Intervention/Treatment heading, along with a revision tag upgrade to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.